BUZZ-Bio‑Rad Laboratories jumps after report Elliott builds stake

Bio-Rad Laboratories, Inc. Class A
Leverage Shares 2X Long SATS Daily ETF

Bio-Rad Laboratories, Inc. Class A

BIO

0.00

Leverage Shares 2X Long SATS Daily ETF

SATG

0.00

** Shares of U.S. diagnostics supplier Bio-Rad Laboratories BIO.N up 7% at $265.01 premarket

** The Wall Street Journal reports activist investor Elliott Investment Management has built a sizeable stake in co

** Elliott plans to push the company to boost its underperforming stock price - WSJ

** Report also says Elliott has built a stake in German biopharma equipment supplier Sartorius SATG.DE, in which Bio‑Rad is an investor

** Exact size of Elliott’s stakes in Bio‑Rad or Sartorius is not disclosed in the report

** Reuters could not immediately verify the report; Elliott, Bio‑Rad and Sartorius did not respond to requests for comment

** As of last close, BIO stock down 18.3% YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.